Accuray (ARAY)

• Market cap: $181M
• 1 day: -1.24%
• 5 days: 1.92%
• 1 month: -1.85%
• 3 months: 29.27%
• 6 months: -14.97%
• Year to date: -18.46%
• 1 year: -16.32%
• 5 years: -32.34%
• 10 years: -75.08%
• Sector: Healthcare
• Industry: Medical Devices

About: Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.

Employees: 990

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

100% more call options, than puts

Call options by funds: $50K | Put options by funds: $25K

15.37% more ownership

Funds ownership: 55.64% [Q1] → 71.0% (+15.37%) [Q2]

2% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 41

0% more funds holding in top 10

Funds holding in top 10: 1 [Q1] → 1 (+0) [Q2]

0% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 16

2% less funds holding

Funds holding: 128 [Q1] → 126 (-2) [Q2]

8% less capital invested

Capital invested by funds: $103M [Q1] → $94.6M (-$7.94M) [Q2]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $5
• Avg. target: $5
• High target: $5

1 analyst rating

• positive: 1 100%
• neutral: 0 0%
• negative: 0 0%

BTIG Maria Thibault

$5

Buy Maintained

14 Aug 2025